Citation Impact
Citing Papers
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
2009
Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
2006
The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs
2019
Expression of Frzb/Secreted Frizzled-Related Protein 3, a Secreted Wnt Antagonist, in Human Androgen-Independent Prostate Cancer PC-3 Cells Suppresses Tumor Growth and Cellular Invasiveness
2005
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
2010
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
2007
Prognostic Relevance of AGR2 Expression in Breast Cancer
2006
A survey of best practices for RNA-seq data analysis
2016 Standout
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Current knowledge on exosome biogenesis and release
2017 Standout
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
Tumor angiogenesis: causes, consequences, challenges and opportunities
2019
SFRP1 reduction results in an increased sensitivity to TGF-β signaling
2011
Routine Clinical Mutation Profiling of Non–Small Cell Lung Cancer Using Next-Generation Sequencing
2015
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
2008
MEK1/2 inhibitors in the treatment of gynecologic malignancies
2014
Germline development from human pluripotent stem cells toward disease modeling of infertility
2012 StandoutNobel
Epigenetic gene silencing in the Wnt pathway in breast cancer
2008
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Breast Cancer Stem Cells: Current Advances and Clinical Implications
2015
New insights into ovarian cancer pathology
2012
A guide to immunometabolism for immunologists
2016 Standout
Ovarian cancer
2014 Standout
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer
2012
Gene expression profiling of the tumor microenvironment during breast cancer progression
2009
Quality control for plant metabolomics: reporting MSI‐compliant studies
2008 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
2012
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
2008 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
2012
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Precursors to pelvic serous carcinoma and their clinical implications
2009
Pancreatic Adenocarcinoma
2014 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease
2013
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
2012
Bladder cancer
2016 Standout
Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
2007
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
2012
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells
2012
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
2008
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
2009
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Signalling Pathways Implicated in Early Mammary Gland Morphogenesis and Breast Cancer
2006
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
p16 Expression in the Female Genital Tract and Its Value in Diagnosis
2006
MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62
2019
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
2014
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
2009
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
New Therapeutic Challenges in Advanced Bladder Cancer
2012
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
2008
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2−/− mice
2009 StandoutNobel
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
2011
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Amplicon profiles in ovarian serous carcinomas
2007
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Macrophage M1/M2 polarization
2020 Standout
The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomas
2010
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
2012
Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicing
2013
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
2011 Standout
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Ovarian Cancer Development and Metastasis
2010
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
2007
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Macrophage Polarization
2016 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Hereditary gynaecological malignancies: advances in screening and treatment
2012
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Ovarian Cancer
2008
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Ovarian cancer statistics, 2018
2018 Standout
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
2004
Combination therapy in combating cancer
2017 Standout
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
2013
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
The Mammalian Ovary from Genesis to Revelation
2009
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Works of Robert Stöhr being referenced
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
2010
Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma
2011
Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
2013
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
2011
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
2012
KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy
2011
MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
2010
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
2005
Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells
2010
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction
2016
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors
2004
Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A–Induced Angiogenesis
2012
Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes
2013